Raffaella Giambalvo
Assay Development and Clinical Pharmacology Scientist at F-star Biotechnology Ltd. - Cambridge, MA, US
Raffaella Giambalvo's Colleagues at F-star Biotechnology Ltd.
Raffaella Giambalvo's Contact Details
N/A
Cambridge, England, United Kingdom
F-star Biotechnology Ltd.
Raffaella Giambalvo's Company Details
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer. F-star is pioneering the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in cancer therapy. The Company has four second-generation immuno-oncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star's proprietary antibody discovery platform is protected by an extensive intellectual property estate. F-star has over 500 granted patents and pending patent applications relating to its platform technology and product pipeline. The Company has attracted multiple partnerships with biopharma targeting significant unmet needs across several disease areas, including oncology, immunology, and CNS.